Means (SD) for demographic and medication details for subjects treated with either risperidone or conventional APDs first
| Group I Risperidone first (n=6) (mean (SD)) | Group II Conventional APD first (n=6) (mean (SD)) | |
|---|---|---|
| *Two tailed p<0.01, Mann-Whitney test z value=−2.9; CPZ, chlorpromazine. | ||
| Age | 35.5 (6.9) | 38.5 (10.56) |
| Age at onset | 24.83 (6.97) | 24.83 (8.28) |
| Duration of illness (months) | 102.67 (56.55) | 171 (87.42) |
| Duration of risperidone (weeks) | 5.67 (3.01) | 9.67 (5.43) |
| Dose of risperidone (mg/day) | 7.67 (1.97) | 6.83 (1.83) |
| Duration of conventional APD (weeks) | 10.83 (2.86)* | 77.17 (66.75)* |
| Dose of conventional (CPZ equivalents mg/day) | 325 (160.5) | 558.33 (500) |